Psychopharmacological possibilities in the acute disaster setting

Psychiatric Clinics of North America

Volumn 27, Issue 3, 2004, Pages 425-458

  Simon, Asher ^a   Gorman, Jack ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPRAZOLAM; AMITRIPTYLINE; ANTALARMIN; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; CLONIDINE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; DIPHENHYDRAMINE; GLUCOCORTICOID; GLUTAMATE RECEPTOR; HYDROCORTISONE; HYPNOTIC SEDATIVE AGENT; LORAZEPAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NADOLOL; NEUROLEPTIC AGENT; NEUROTRANSMITTER; OPIATE AGONIST; PROPRANOLOL; TEMAZEPAM; TRAZODONE; UNINDEXED DRUG; ZALEPLON; ZOLPIDEM;

AMYGDALOID NUCLEUS; AROUSAL; BRAIN FUNCTION; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; COGNITIVE DEFECT; DISASTER; DISSOCIATION; DRUG EFFECT; FEAR; HIPPOCAMPUS; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MEMORY; NEUROBIOLOGY; NONHUMAN; NORADRENALIN RELEASE; NORADRENERGIC SYSTEM; PHENOMENOLOGY; POSTTRAUMATIC STRESS DISORDER; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; REVIEW; SENSITIZATION; STRESS; SYMPTOMATOLOGY;

ACUTE DISEASE; AMYGDALA; COGNITION DISORDERS; CORTICOTROPIN-RELEASING HORMONE; DISASTERS; GLUTAMIC ACID; HIPPOCAMPUS; HUMANS; MEMORY DISORDERS; NEUROTRANSMITTER AGENTS; NOREPINEPHRINE; PREFRONTAL CORTEX; PSYCHOPHARMACOLOGY; RECEPTORS, N-METHYL-D-ASPARTATE; STRESS DISORDERS, POST-TRAUMATIC;

EID: 4344609467     PISSN: 0193953X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psc.2004.03.004     Document Type: Review

References (225)

1. Rubonis A.V., Bickman L. Psychological impairment in the wake of disaster: the disaster-psychopathology relationship. Psychol Bull. 109:(3):1991;384-399
2. Fordham M. The intersection of gender and social class in disaster: balancing resilience and vulnerability. Int J Mass Emerg Disasters. 17:(1):1999;15-37
3. Solomon S.D. Interventions for acute trauma response. Curr Opin Psychiatry. 12:(2):1999;175-180
4. Katz C.L., Pellegrino L., Pandya A., Ng A., DeLisi L.E. Research on psychiatric outcomes and interventions subsequent to disasters: a review of the literature. Psychiatry Res. 110:(3):2002;201-217
5. Bryant R.A. Early predictors of post-traumatic stress disorder. Biol Psychiatry. 53:(9):2003;789-795
6. Friedman M.J. Future pharmacotherapy for post-traumatic stress disorder: prevention and treatment. Psychiatr Clin North Am. 25:(2):2002;427-441
7. Kessler R.C., Sonnega A., Bromet E., Hughes M., Nelson C.B. Post-traumatic stress disorder in the national comorbidity survey. Arch Gen Psychiatry. 52:(12):1995;1048-1060
8. Breslau N., Davis G.C., Andreski P., Peterson E. Traumatic events and post-traumatic stress disorder in an urban population of young adults. Arch Gen Psychiatry. 48:(3):1991;216-222
9. Sullivan G.M., Gorman J.M. Finding a home for post-traumatic stress disorder in biological psychiatry. Is it a disorder of anxiety, mood, stress, or memory? Psychiatr Clin North Am. 25:(2):2002;463-468
10. Charney D.S., Drevets W.C. Neurobiological basis of anxiety disorders. Davis K.L., Charney D., Coyle J.T., Nemeroff C. Neuropsychopharmacology: the fifth generation of progress. 5th edition:2002;901-930 Lippincott Williams & Wilkins, Philadelphia
11. Pitman R.K., Shalev A.Y., Orr S.P. Post-traumatic stress disorder: emotion, conditioning and memory. Gazzaniga M.S. The new cognitive neurosciences. 2nd edition:2000;1133-1147 MIT Press, Cambridge (MA)
12. Shalev A.Y. Biological responses to disasters. Psychiatr Q. 71:(3):2000;277-288
13. LeDoux J.E., Iwata J., Cicchetti P., Reis D.J. Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear. J Neurosci. 8:(7):1988;2517-2529
14. Shalev A.Y. Acute stress reactions in adults. Biol Psychiatry. 51:(7):2002;532-543
15. Morgan I., Charles A., Krystal J.H., Southwick S.M. Toward early pharmacological posttraumatic stress intervention. Biol Psychiatry. 53:(9):2003;834-843
16. Davis M. Neural circuitry of anxiety and stress disorders. Davis K.L., Charney D., Coyle J.T., Nemeroff C. Neuropsychopharmacology: the fifth generation of progress. 5th edition:2002;931-951 Lippincott Williams & Wilkins, Philadelphia
17. Whalen P.J. Fear, vigilance and ambiguity: initial neuroimaging studies of the human amygdala. Current Directions in Psychological Science. 7:(6):1998;177-188
18. Rauch S.L., Shin L.M. Structural and functional imaging of anxiety and stress disorders. Davis K.L., Charney D., Coyle J.T., Nemeroff C. Neuropsychopharmacology: the fifth generation of progress. 5th edition:2002;953-966 Lippincott Williams & Wilkins, Philadelphia
19. Armony J.L., LeDoux J.E. How danger is encoded: toward a systems, cellular, and computational understanding of cognitive-emotional interactions in fear. Gazzaniga M.S. The new cognitive neurosciences. 2nd edition:2000;MIT Press, Cambridge (MA)
20. LeDoux J.E. The emotional brain. 1996;Simon and Schuster, New York
21. Rogan M.T., Staubli U.V., LeDoux J.E. Fear conditioning induces associative long-term potentiation in the amygdala. Nature. 390:(6660):1997;604- 607
22. Shalev A.Y. Psychophysiological expression of risk factors for PTSD. Yehuda R. Risk factors for post-traumatic stress disorder. 1999;143-162 American Psychiatric Press, Washington (DC)
23. Shalev A.Y., Ragel-Fuchs Y., Pitman R.K. Conditioned fear and psychological trauma. Biol Psychiatry. 31:(9):1992;863-865
24. Nijenhuis E.R.S., van der Hart O., Steele K. The emerging psychobiology of trauma-related dissociation and dissociative disorders. D'Haenen H., den Boer J.A., Willner P. Biological Psychiatry. 2002;1079-1098 Wiley, London
25. Rauch S.L., Whalen P.J., Shin L.M., et al. Exaggerated amygdala response to masked facial stimuli in post-traumatic stress disorder: a functional MRI study. Biol Psychiatry. 47:(9):2000;769-776
26. Morris J.S., Frith C.D., Perrett D.I., et al. A differential neural response in the human amygdala to fearful and happy facial expressions. Nature. 383:(6603):1996;812-815
27. Blair R.J., Morris J.S., Frith C.D., Perrett D.I., Dolan R.J. Dissociable neural responses to facial expressions of sadness and anger. Brain. 122:1999;883-893
28. LeDoux J.E., Romanski L., Xagoraris A. Indelibility of subcortical emotional memories. J Cogn Neurosci. (1):1989;238-243
29. Brewin C.R. A cognitive neuroscience account of post-traumatic stress disorder and its treatment. Behav Res Ther. 39:(4):2001;373-393
30. Sherry D.F., Jacobs L.F., Gaulin S.J. Spatial memory and adaptive specialization of the hippocampus. Trends Neurosci. 15:(8):1992;298-303
31. Baxter M.G., Parker A., Lindner C.C., Izquierdo A.D., Murray E.A. Control of response selection by reinforcer value requires interaction of amygdala and orbital prefrontal cortex. J Neurosci. 20:(11):2000;4311-4319
32. Morgan M.A., LeDoux J.E. Differential contribution of dorsal and ventral medial prefrontal cortex to the acquisition and extinction of conditioned fear in rats. Behav Neurosci. 109:(4):1995;681-688
33. Morgan M.A., Romanski L.M., LeDoux J.E. Extinction of emotional learning: contribution of medial prefrontal cortex. Neurosci Lett. 163:(1):1993;109-113
34. Damasio A.R., Tranel D., Damasio H. Individuals with sociopathic behavior caused by frontal damage fail to respond autonomically to social stimuli. Behav Brain Res. 41:(2):1990;81-94
35. Krystal J.H., Bennett A.L., Bremner J.D., Southwick S.M., Charney D.S. Toward a cognitive neuroscience of dissociation and altered memory functions in post-traumatic stress disorder. Friedman M.J., Charney D.S., Deutch A.Y. Neurobiological and clinical consequences of stress: from normal adaptation to PTSD. 1995;239-269 Lippincott-Raven, Philadelphia
36. Aston-Jones G., Valentino R.J., Van Bockstaele E.J., Meyerson A.T. Locus coeruleus, stress, and PTSD: Neurobiological and clinical parallels. Murburg M. Catecholamine function in post-traumatic stress disorder: emerging concepts. 1994;17-62 APA Press, Washington (DC)
37. Chambers R.A., Bremner J.D., Moghaddam B., Southwick S.M., Charney D.S., Krystal J.H. Glutamate and post-traumatic stress disorder: toward a psychobiology of dissociation. Semin Clin Neuropsychiatry. 4:(4):1999;274-281
38. Armanini M.P., Hutchins C., Stein B.A., Sapolsky R.M. Glucocorticoid endangerment of hippocampal neurons is NMDA-receptor dependent. Brain Res. 532:1990;7-12
39. Stein-Behrens B.A., Lin W.J., Sapolsky R.M. Physiological elevations of glucocorticoids potentiate glutamate accumulation in the hippocampus. J Neurochem. 63:(2):1994;596-602
40. Thomas R.J. Excitatory amino acids in health and disease. J Am Geriatr Soc. 43:(11):1995;1279-1289
41. Southwick S.M., Bremner J.D., Rasmusson A., Morgan C.A. 3rd, Arnsten A., Charney D.S. Role of norepinephrine in the pathophysiology and treatment of post-traumatic stress disorder. Biol Psychiatry. 46:(9):1999;1192-1204
42. Zigmond M.J., Finlay J.M., Sved A.F. Neurochemical studies of central noradrenergic responses to acute and chronic stress: implications for normal and abnormal behavior. Friedman M.J., Charney D.S., Deutch A.Y. Neurobiological and clinical consequences of stress: from normal adaptation to PTSD. 1995;45-60 Lippincott-Raven, Philadelphia
43. Arnsten A.F.T. Catecholamine modulation of prefrontal cortical cognitive function. Trends Cogn Sci. 2:(11):1998;436-447
44. Arnsten A.F. The biology of being frazzled. Science. 280:(5370): 1998;1711-1712
45. Birnbaum S., Gobeske K.T., Auerbach J., Taylor J.R., Arnsten A.F. A role for norepinephrine in stress-induced cognitive deficits: alpha-1-adrenoceptor mediation in the prefrontal cortex. Biol Psychiatry. 46:(9):1999;1266-1274
46. Cahill L., Prins B., Weber M., McGaugh J.L. β-Adrenergic activation and memory for emotional events. Nature. 371:(6499):1994;702-704
47. McGaugh J.L., Cahill L., Roozendaal B. Involvement of the amygdala in memory storage: interaction with other brain systems. Proc Natl Acad Sci U S A. 93:(24):1996;13508-13514
48. Southwick S.M., Davis M., Horner B., et al. Relationship of enhanced norepinephrine activity during memory consolidation to enhanced long-term memory in humans. Am J Psychiatry. 159:(8):2002;1420-1422
49. McGaugh J.L. Memory-a century of consolidation. Science. 287:(5451):2000;248-251
50. Friedman M.J. What might the psychobiology of posttraumatic stress disorder teach us about future approaches to pharmacotherapy? J Clin Psychiatry. 61:(Suppl 7):2000;44-51
51. Herman J.P., Cullinan W.E. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci. 20:(2):1997;78-84
52. de Loos W.S. The psychobiology of post-traumatic stress disorder. Griez E.J.L., Faravelli C., Nutt D., Zohar D. Anxiety disorders: an introduction to clinical management and research. 2001;223-244 John Wiley & Sons, Indianapolis
53. LeDoux J.E. Setting stress into motion: brain mechanisms of stimulus evaluation. Friedman M.J., Charney D.S., Deutch A.Y. Neurobiological and clinical consequences of stress: from normal adaptation to PTSD. 1995;125-134 Lippincott-Raven, Philadelphia
54. McNally R.J., Kaspi S.P., Riemann B.C., Zeitlin S.B. Selective processing of threat cues in posttraumatic stress disorder. J Abnorm Psychol. 99:(4):1990;398-402
55. Ehlers A., Clark D.M. A cognitive model of posttraumatic stress disorder. Behav Res Ther. 38:(4):2000;319-345
56. Yehuda R., Steiner A., Kahana B., et al. Alexithymia in Holocaust survivors with and without PTSD. J Trauma Stress. 10:(1):1997;93-100
57. Antelman S.M. Time-dependent sensitization as the cornerstone for a new approach to pharmacotherapy: drugs as foreign/stressful stimuli. Drug Dev Res. 14:(1):1988;1-30
58. Adamec R. Transmitter systems involved in neural plasticity underlying increased anxiety and defense - implications for understanding anxiety following traumatic stress. Neurosci Biobehav Rev. 21:(6):1997;755-765
59. Kim J.J., Foy M.R., Thompson R.F. Behavioral stress modifies hippocampal plasticity through N-methyl-D-aspartate receptor activation. Proc Natl Acad Sci U S A. 93:(10):1996;4750-4753
60. *1. J Abnorm Psychol. 101:(3):1992;452-459
61. McFarlane A.C. Avoidance and intrusion in posttraumatic stress disorder. J Nerv Ment Dis. 180:(7):1992;439-445
62. McFarlane A.C. Posttraumatic stress disorder: a model of the longitudinal course and the role of risk factors. J Clin Psychiatry. 61:(Suppl 5):2000;15-20. [discussion 21-3]
63. Brandes D., Ben-Schachar G., Gilboa A., Bonne O., Freedman S., Shalev A.Y. PTSD symptoms and cognitive performance in recent trauma survivors. Psychiatry Res. 110:(3):2002;231-238
64. van der Kolk B.A. Trauma and memory. van der Kolk B.A., McFarlane A.C., Weisaeth L. Traumatic stress. 1996;279-302 Guilford, New York
65. Dunmore E., Clark D.M., Ehlers A. Cognitive factors involved in the onset and maintenance of post-traumatic stress disorder (PTSD) after physical or sexual assault. Behav Res Ther. 37:(9):1999;809-829
66. *2. J Consult Clin Psychol. 66:(3):1998;507-512
67. Yehuda R. Clinical relevance of biologic findings in PTSD. Psychiatr Q. 73:(2):2002;123-133
68. Bremner J.D., Licinio J., Darnell A., Krystal J.H., et al. Elevated CSF corticotropin-releasing factor concentrations in post-traumatic stress disorder. Am J Psychiatry. 154:(5):1997;624-629
69. Quirk G.J., Russo G.K., Barron J.L., Lebron K. The role of ventromedial prefrontal cortex in the recovery of extinguished fear. J Neurosci. 20:(16):2000;6225-6231
70. Shin L.M., McNally R.J., Kosslyn S.M., et al. Regional cerebral blood flow during script-driven imagery in childhood sexual abuse-related PTSD: A PET investigation. Am J Psychiatry. 156:(4):1999;575-584
71. Bremner J.D., Staib L.H., Kaloupek D., Southwick S.M., Soufer R., Charney D.S. Neural correlates of exposure to traumatic pictures and sound in Vietnam combat veterans with and without posttraumatic stress disorder: a positron emission tomography study. Biol Psychiatry. 45:(7):1999;806-816
72. Orr S.P., Metzger L.J., Lasko N.B., Macklin M.L., Peri T., Pitman R.K. De novo conditioning in trauma-exposed individuals with and without post-traumatic stress disorder. J Abnorm Psychol. 109:(2):2000;290-298
73. Peri T., Ben-Shakhar G., Orr S.P., Shalev A.Y. Psychophysiologic assessment of aversive conditioning in post-traumatic stress disorder. Biol Psychiatry. 47:(6):2000;512-519
74. Bremner J.D., Southwick S., Brett E., Fontana A., Rosenheck R., Charney D.S. Dissociation and posttraumatic stress disorder in Vietnam combat veterans. Am J Psychiatry. 149:(3):1992;328-332
75. Marmar C.R., Weiss D.S., Schlenger W.E., Fairbank J.A., et al. Peritraumatic dissociation and post-traumatic stress in male Vietnam theater veterans. Am J Psychiatry. 151:(6):1994;902-907
76. Koopman C., Classen C., Spiegel D.A. Predictors of post-traumatic stress symptoms among survivors of the Oakland/Berkeley, Calif., firestorm. Am J Psychiatry. 151:(6):1994;888-894
77. Bryant R.A., Harvey A.G. Acute stress disorder: a critical review of diagnostic issues. Clin Psychol Rev. 17:(7):1997;757-773
78. Zoellner L.A., Jaycox L.H., Watlington C.G., Foa E.B. Are the dissociative criteria in ASD useful? J Trauma Stress. 16:(4):2003;341-350
79. Heresco-Levy U., Javitt D.C. The role of N-methyl-D-aspartate (NMDA) receptor-mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes. Eur Neuropsychopharmacol. 8:(2):1998;141-152
80. Miserendino M.J., Sananes C.B., Melia K.R., Davis M. Blocking of acquisition but not expression of conditioned fear-potentiated startle by NMDA antagonists in the amygdala. Nature. 345:(6277):1990;716-718
81. Teyler T.J., DiScenna P. Long-term potentiation. Annu Rev Neurosci. 10:1987;131-161
82. Morris R.G., Anderson E., Lynch G.S., Baudry M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature. 319:(6056):1986;774-776
83. Tonkiss J., Morris R.G., Rawlins J.N. Intra-ventricular infusion of the NMDA antagonist AP5 impairs performance on a non-spatial operant DRL task in the rat. Exp Brain Res. 73:(1):1988;181-188
84. Falls W.A., Miserendino M.J., Davis M. Extinction of fear-potentiated startle: blockade by infusion of an NMDA antagonist into the amygdala. J Neurosci. 12:(3):1992;854-863
85. Shors T.J., Mathew P.R. NMDA receptor antagonism in the lateral/basolateral but not central nucleus of the amygdala prevents the induction of facilitated learning in response to stress. Learn Mem. 5:(3):1998;220-230
86. Seligman M.E., Maier S.F. Failure to escape traumatic shock. J Exp Psychol. 74:(1):1967;1-9
87. Anisman H., Ritch M., Sklar L.S. Noradrenergic and dopaminergic interactions in escape behavior: analysis of uncontrollable stress effects. Psychopharmacology (Berl). 74:(3):1981;263-268
88. *1. Biol Psychiatry. 26:(5):1989;438-462
89. Charney D.S., Deutch A.Y., Krystal J.H., Southwick S.M., Davis M. Psychobiologic mechanisms of post-traumatic stress disorder. Arch Gen Psychiatry. 50:(4):1993;295-305
90. Blank T., Nijholt I., Eckart K., Spiess J. Priming of long-term potentiation in mouse hippocampus by corticotropin-releasing factor and acute stress: implications for hippocampus-dependent learning. J Neurosci. 22:(9):2002;3788-3794
91. McEwen B.S. The neurobiology of stress: from serendipity to clinical relevance. Brain Res. 886:2000;172-189
92. Vasterling J.J., Brailey K., Constans J.I., Sutker P.B. Attention and memory dysfunction in post-traumatic stress disorder. Neuropsychology. 12:(1):1998;125-133
93. Uddo M., Vasterling J.J., Brailey K., Sutker P.B. Memory and attention in combat-related post-traumatic stress disorder (PTSD). Journal of Psychotherapy and Behavioral Assessment. 15:1993;43-52
94. Bremner J.D., Scott T.M., Delaney R.C., et al. Deficits in short-term memory in posttraumatic stress disorder. Am J Psychiatry. 150:(7):1993;1015-1019
95. Bremner J.D., Randall P., Scott T.M., et al. MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am J Psychiatry. 152:(7):1995;973-981
96. Liang K.C., Juler R.G., McGaugh J.L. Modulating effects of post-training epinephrine on memory: involvement of the amygdala noradrenergic system. Brain Res. 368:(1):1986;125-133
97. Pitman R.K. Post-traumatic stress disorder, hormones, and memory. Biol Psychiatry. 26:(3):1989;221-223
98. Shalev A.Y., Sahar T., Freedman S., et al. A prospective study of heart rate response following trauma and the subsequent development of post-traumatic stress disorder. Arch Gen Psychiatry. 55:(6):1998;553-559
99. *1. J Abnorm Psychol. 109:(2):2000;341-344
100. Nisenbaum L.K., Abercrombie E.D. Presynaptic alterations associated with enhancement of evoked release and synthesis of norepinephrine in hippocampus of chronically cold-stressed rats. Brain Res. 608:(2):1993;280-287
101. Southwick S.M., Yehuda R., Morgan C.A. Clinical Studies of neurotransmitter alterations in post-traumatic stress disorder. Friedman M.J., Charney D.S., Deutch A.Y. Neurobiological and clinical consequences of stress: from normal adaptation to PTSD. 1995;335-349 Lippincott-Raven, Philadelphia
102. Simson P.E., Weiss J.M. Altered electrophysiology of the locus coeruleus following uncontrollable stress: relationship to anxiety and anxiolytic action. Progress in Psychiatry. 42:1994;63-86
103. Perry B.D., Giller E.L. Jr., Southwick S.M. Altered platelet alpha 2-adrenergic binding sites in post-traumatic stress disorder. Am J Psychiatry. 144:(11):1987;1511-1512
104. Yehuda R., Southwick S., Giller E.L., Ma X., Mason J.W. Urinary catecholamine excretion and severity of PTSD symptoms in Vietnam combat veterans. J Nerv Ment Dis. 180:(5):1992;321-325
105. Geracioti T.D. Jr., Baker D.G., Ekhator N.N., et al. CSF norepinephrine concentrations in post-traumatic stress disorder. Am J Psychiatry. 158:(8):2001;1227-1230
106. Southwick S.M., Krystal J.H., Morgan C.A., Johnson D., et al. Abnormal noradrenergic function in post-traumatic stress disorder. Arch Gen Psychiatry. 50:(4):1993;266-274
107. Yehuda R. Sensitization of the hypothalamic pituitary-adrenal axis in posttraumatic stress disorder. Ann N Y Acad Sci. 821:1997;57-75
108. Yehuda R. Psychoneuroendocrinology of post-traumatic stress disorder. Psychiatr Clin North Am. 21:(2):1998;359-379
109. Yehuda R., Teicher M.H., Trestman R.L., Levengood R.A., Siever L.J. Cortisol regulation in post-traumatic stress disorder and major depression: a chronobiological analysis. Biol Psychiatry. 40:(2):1996;79-88
110. Yehuda R., Boisoneau D., Lowy M.T., Giller E.L. Jr. Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without post-traumatic stress disorder. Arch Gen Psychiatry. 52:(7):1995;583-593
111. Yehuda R., Lowy M.T., Southwick S.M., Shaffer D., Giller E.L. Jr. Lymphocyte glucocorticoid receptor number in post-traumatic stress disorder. Am J Psychiatry. 148:(4):1991;499-504
112. Baker D.G., West S.A., Nicholson W.E., et al. Serial CSF corticotropin-releasing hormone levels and adrenocortical activity in combat veterans with post-traumatic stress disorder. Am J Psychiatry. 156:(4):1999;585-588
113. Heim C., Newport D.J., Heit S., et al. Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA. 284:(5):2000;592-597
114. Smith M.A., Davidson J., Ritchie J.C., et al. The corticotropin-releasing hormone test in patients with post-traumatic stress disorder. Biol Psychiatry. 26:(4):1989;349-355
115. Resnick H.S., Yehuda R., Pitman R.K., Foy D.W. Effect of previous trauma on acute plasma cortisol level following rape. Am J Psychiatry. 152:(11):1995;1675-1677
116. McFarlane A.C., Atchison M., Yehuda R. The acute stress response following motor vehicle accidents and its relation to PTSD. Ann N Y Acad Sci. 821:1997;437-441
117. Delahanty D.L., Raimonde A.J., Spoonster E. Initial posttraumatic urinary cortisol levels predict subsequent PTSD symptoms in motor vehicle accident victims. Biol Psychiatry. 48:(9):2000;940-947
118. Gould E., Tanapat P., Rydel T., Hastings N. Regulation of hippocampal neurogenesis in adulthood. Biol Psychiatry. 48:(8):2000;715-720
119. McEwen B.S. Stress and hippocampal plasticity. Annu Rev Neurosci. 22:1999;105-122
120. Lupien S.J., McEwen B.S. The acute effects of corticosteroids on cognition: integration of animal and human model studies. Brain Res Brain Res Rev. 24:(1):1997;1-27
121. McEwen B.S., Sapolsky R.M. Stress and cognitive function. Curr Opin Neurobiol. 5:(2):1995;205-216
122. Bremner J.D., Randall P., Vermetten E., et al. Magnetic resonance imaging-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse - a preliminary report. Biol Psychiatry. 41:(1):1997;23-32
123. Gurvits T.V., Shenton M.E., Hokama H., et al. Magnetic resonance imaging study of hippocampal volume in chronic, combat-related posttraumatic stress disorder. Biol Psychiatry. 40:(11):1996;1091-1099
124. Stein M.B., Koverola C., Hanna C., Torchia M.G., McClarty B. Hippocampal volume in women victimized by childhood sexual abuse. Psychol Med. 27:(4):1997;951-959
125. Lupien S.J., Lepage M. Stress, memory, and the hippocampus: can't live with it, can't live without it. Behav Brain Res. 127:2001;137-158
126. Cahill L., Pham C.A., Setlow B. Impaired memory consolidation in rats produced with beta-adrenergic blockade. Neurobiol Learn Mem. 74:(3):2000;259-266
127. van Stegeren A.H., Everaerd W., Cahill L., McGaugh J.L., Gooren L.J. Memory for emotional events: differential effects of centrally versus peripherally acting beta-blocking agents. Psychopharmacology (Berl). 138:1998;305-310
128. Pitman R.K., Sanders K.M., Zusman R.M., et al. Pilot study of secondary prevention of post-traumatic stress disorder with propranolol. Biol Psychiatry. 51:(2):2002;189-192
129. Vaiva G., Ducrocq F., Jezequel K., et al. Immediate treatment with propranolol decreases post-traumatic stress disorder two months after trauma. Biol Psychiatry. 54:(9):2003;947-949
130. Przybyslawski J., Roullet P., Sara S.J. Attenuation of emotional and nonemotional memories after their reactivation: role of beta-adrenergic receptors. J Neurosci. 19:(15):1999;6623-6628
131. Taylor F., Cahill L. Propranolol for re-emergent posttraumatic stress disorder following an event of retraumatization: a case study. J Trauma Stress. 15:(5):2002;433-437
132. Seidenbecher T., Reymann K.G., Balschun D. A post-tetanic time window for the reinforcement of long-term potentiation by appetitive and aversive stimuli. Proc Natl Acad Sci U S A. 94:(4):1997;1494-1499
133. Sacchetti B., Lorenzini C.A., Baldi E., Tassoni G., Bucherelli C. Auditory thalamus, dorsal hippocampus, basolateral amygdala, and perirhinal cortex role in the consolidation of conditioned freezing to context and to acoustic conditioned stimulus in the rat. J Neurosci. 19:(21):1999;9570-9578
134. Kinzie J.D., Leung P. Clonidine in Cambodian patients with post-traumatic stress disorder. J Nerv Ment Dis. 177:(9):1989;546-550
135. Kolb L.C. PTSD: psychopathology and the startle response. Psychiatr Q. 62:(3):1991;233-250
136. Horrigan J.P. Guanfacine for PTSD nightmares. J Am Acad Child Adolesc Psychiatry. 35:(8):1996;975-976
137. Raskind M.A., Peskind E.R., Kanter E.D., et al. Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study. Am J Psychiatry. 160:(2):2003;371-373
138. Study R.E., Barker J.L. Cellular mechanisms of benzodiazepine action. JAMA. 247:(15):1982;2147-2151
139. Bremner J.D., Innis R.B., Southwick S.M., Staib L., Zoghbi S., Charney D.S. Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related post-traumatic stress disorder. Am J Psychiatry. 157:(7):2000;1120-1126
140. Lippa A.S., Klepner C.A., Yunger L., Sano M.C., Smith W.V., Beer B. Relationship between benzodiazepine receptors and experimental anxiety in rats. Pharmacol Biochem Behav. 9:(6):1978;853-856
141. Weizman R., Weizman A., Kook K.A., Vocci F., Deutsch S.I., Paul S.M. Repeated swim stress alters brain benzodiazepine receptors measured in vivo. J Pharmacol Exp Ther. 249:(3):1989;701-707
142. Braun P., Greenberg D., Dasberg H., Lerer B. Core symptoms of posttraumatic stress disorder unimproved by alprazolam treatment. J Clin Psychiatry. 51:(6):1990;236-238
143. Gelpin E., Bonne O., Peri T., Brandes D., Shalev A.Y. Treatment of recent trauma survivors with benzodiazepines: a prospective study. J Clin Psychiatry. 57:(9):1996;390-394
144. Walker D.L., Davis M. The role of amygdala glutamate receptors in fear learning, fear-potentiated startle, and extinction. Pharmacol Biochem Behav. 71:(3):2002;379-392
145. Bouton M.E., Kenney F.A., Rosengard C. State-dependent fear extinction with two benzodiazepine tranquilizers. Behav Neurosci. 104:(1):1990;44-55
146. Drugan R.C., Ryan S.M., Minor T.R., Maier S.F. Librium prevents the analgesia and shuttlebox escape deficit typically observed following inescapable shock. Pharmacol Biochem Behav. 21:(5):1984;749-754
147. Grant S.J., Huang Y.H., Redmond D.E. Jr. Benzodiazepines attenuate single unit activity in the locus coeruleus. Life Sci. 27:(23):1980;2231-2236
148. Tomaz C., Dickinson-Anson H., McGaugh J.L., Souza-Silva M.A., Viana M.B., Graeff F.G. Localization in the amygdala of the amnestic action of diazepam on emotional memory. Behav Brain Res. 58:1993;99-105
149. Nutt D.J. The psychobiology of posttraumatic stress disorder. J Clin Psychiatry. 61:(Suppl 5):2000;24-29. [discussion 30-2]
150. Owens M.J., Vargas M.A., Knight D.L., Nemeroff C.B. The effects of alprazolam on corticotropin-releasing factor neurons in the rat brain: acute time course, chronic treatment and abrupt withdrawal. J Pharmacol Exp Ther. 258:(1):1991;349-356
151. Mellman T.A., Byers P.M., Augenstein J.S. Pilot evaluation of hypnotic medication during acute traumatic stress response. J Trauma Stress. 11:(3):1998;563-569
152. Cartwright R.D., Kravitz H.M., Eastman C.I., Wood E. REM latency and the recovery from depression: getting over divorce. Am J Psychiatry. 148:(11):1991;1530-1535
153. Task Force on Psychiatric Dimensions of Disaster. Biomedical perspectives. Available at: http://www.psych.org/disaster/dpc_biomedical.cfm. Accessed January 2, 2004.
154. White D.P. Tragedy and insomnia. N Engl J Med. 345:(25):2001;1846-1848
155. Lavie P. Sleep disturbances in the wake of traumatic events. N Engl J Med. 345:(25):2001;1825-1832
156. Valentino R.J., Curtis A.L., Parris D.G., Wehby R.G. Antidepressant actions on brain noradrenergic neurons. J Pharmacol Exp Ther. 253:(2):1990;833-840
157. Kehne J., De Lombaert S. Nonpeptidic CRF1 receptor antagonists for the treatment of anxiety, depression and stress disorders. Curr Drug Target CNS Neurol Disord. 1:(5):2002;467-493
158. Zorrilla E.P., Valdez G.R., Nozulak J., Koob G.F., Markou A. Effects of antalarmin, a CRF type 1 receptor antagonist, on anxiety-like behavior and motor activation in the rat. Brain Res. 952:(2):2002;188-199
159. Spina M.G., Basso A.M., Zorrilla E.P., et al. Behavioral effects of central administration of the novel CRF antagonist astressin in rats. Neuropsychopharmacology. 22:(3):2000;230-239
160. Habib K.E., Weld K.P., Rice K.C., et al. Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates. Proc Natl Acad Sci U S A. 97:(11):2000;6079-6084
161. Deak T., Nguyen K.T., Ehrlich A.L., et al. The impact of the nonpeptide corticotropin-releasing hormone antagonist antalarmin on behavioral and endocrine responses to stress. Endocrinology. 140:(1):1999;79-86
162. Schelling G., Briegel J., Roozendaal B., Stoll C., Rothenhausler H.B., Kapfhammer H.P. The effect of stress doses of hydrocortisone during septic shock on post-traumatic stress disorder in survivors. Biol Psychiatry. 50:(12):2001;978-985
163. Cohen H., Benjamin J., Kaplan Z., Kotler M. Administration of high-dose ketoconazole, an inhibitor of steroid synthesis, prevents posttraumatic anxiety in an animal model. Eur Neuropsychopharmacol. 10:(6):2000;429-435
164. Korf J., Bunney B.S., Aghajanian G.K. Noradrenergic neurons: morphine inhibition of spontaneous activity. Eur J Pharmacol. 25:(2):1974;165-169
165. Freedman J.E., Aghajanian G.K. Opiate and alpha 2-adrenoceptor responses of rat amygdaloid neurons: colocalization and interactions during withdrawal. J Neurosci. 5:(11):1985;3016-3024
166. Huang G., Besson J., Bernard J. Intravenous morphine depresses the transmission of noxious messages to the nucleus centralis of the amygdala. Eur J Pharmacol. 236:(3):1993;449-456
167. Madden J. 4th, Akil H., Patrick R.L., Barchas J.D. Stress-induced parallel changes in central opioid levels and pain responsiveness in the rat. Nature. 265:(5592):1977;358-360
168. Pitman R.K., van der Kolk B.A., Orr S.P., Greenberg M.S. Naloxone-reversible analgesic response to combat-related stimuli in post-traumatic stress disorder. A pilot study. Arch Gen Psychiatry. 47:(6):1990;541-544
169. McGaugh J.L. Involvement of hormonal and neuromodulatory systems in the regulation of memory storage. Annu Rev Neurosci. 12:1989;255-287
170. Saxe G., Stoddard F., Courtney D., et al. Relationship between acute morphine and the course of PTSD in children with burns. J Am Acad Child Adolesc Psychiatry. 40:(8):2001;915-921
171. Duman R.S., Nakagawa S., Malberg J. Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology. 25:(6):2001;836-844
172. Blaha J., Svobodova K., Kapounkova Z. Therapeutical aspects of using citalopram in burns. Acta Chir Plast. 41:(1):1999;25-32
173. Robert R., Blakeney P.E., Villarreal C., Rosenberg L., Meyer W.J. III. Imipramine treatment in pediatric burn patients with symptoms of acute stress disorder: A pilot study. J Am Acad Child Adolesc Psychiatry. 38:(7):1999;873-882
174. A National Center for PTSD fact sheet. Recommendations for pharmacological treatment of acute stress reactions. Available at: http://www.ncptsd.org/facts/disasters/fs_medication_disaster.html. Accessed October 10, 2003.
175. Olfson M., Lewis-Fernandez R., Weissman M.M., et al. Psychotic symptoms in an urban general medicine practice. Am J Psychiatry. 159:(8):2002;1412-1419
176. Eidelman I., Seedat S., Stein D.J. Risperidone in the treatment of acute stress disorder in physically traumatized in-patients. Depress Anxiety. 11:(4):2000;187-188
177. Stanovic J.K., James K.A., Vandevere C.A. The effectiveness of risperidone on acute stress symptoms in adult burn patients: a preliminary retrospective pilot study. J Burn Care Rehabil. 22:(3):2001;210-213
178. Friedman M.J. Neurobiological sensitization models of post-traumatic stress disorder: their possible relevance to multiple chemical sensitivity syndrome. Toxicol Ind Health. 10:1994;449-462
179. Grillon C., Southwick S.M., Charney D.S. The psychobiological basis of posttraumatic stress disorder. Mol Psychiatry. 1:(4):1996;278-297
180. Iancu I., Rosen Y., Moshe K. Antiepileptic drugs in posttraumatic stress disorder. Clin Neuropharmacol. 25:(4):2002;225-229
181. Krystal J.H., Karper L.P., Bennett A., et al. Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans. Psychopharmacology (Berl). 135:(3):1998;213-229
182. Krystal J.H., D'Souza D.C., Karper L.P., et al. Interactive effects of subanesthetic ketamine and haloperidol in healthy humans. Psychopharmacology (Berl). 145:(2):1999;193-204
183. Anand A., Charney D.S., Oren D.A., et al. Attenuation of the neuropsychiatric effects of ketamine with lamotrigine: support for hyperglutamatergic effects of N-methyl-D-aspartate receptor antagonists. Arch Gen Psychiatry. 57:(3):2000;270-276
184. Watanabe Y., Gould E., Cameron H.A., Daniels D.C., McEwen B.S. Phenytoin prevents stress- and corticosterone-induced atrophy of CA3 pyramidal neurons. Hippocampus. 2:(4):1992;431-435
185. McFarlane A.C. Epidemiological evidence about the relationship between PTSD and alcohol abuse: the nature of the association. Addict Behav. 23:(6):1998;813-825
186. Maes M., Delmeire L., Mylle J., Altamura C. Risk and preventive factors of post-traumatic stress disorder (PTSD): alcohol consumption and intoxication prior to a traumatic event diminishes the relative risk to develop PTSD in response to that trauma. J Affect Disord. 63:2001;113-121
187. Shirao I., Tsuda A., Ida Y., et al. Effect of acute ethanol administration on noradrenaline metabolism in brain regions of stressed and nonstressed rats. Pharmacol Biochem Behav. 30:(3):1988;769-773
188. Calton J.L., Wilson W.A., Moore S.D. Magnesium-dependent inhibition of N-methyl-D-aspartate receptor-mediated synaptic transmission by ethanol. J Pharmacol Exp Ther. 287:(3):1998;1015-1019
189. Faingold C.L., N'Gouemo P., Riaz A. Ethanol and neurotransmitter interactions - from molecular to integrative effects. Prog Neurobiol. 55:(5):1998;509-535
190. Tatemoto K. Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc Natl Acad Sci U S A. 79:(18):1982;5485-5489
191. Illes P., Regenold J.T. Interaction between neuropeptide Y and noradrenaline on central catecholamine neurons. Nature. 344:(6261):1990;62-63
192. Lundberg J.M., Terenius L., Hokfelt T., Goldstein M. High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man. Neurosci Lett. 42:(2):1983;167-172
193. Heilig M., Koob G.F., Ekman R., Britton K.T. Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends Neurosci. 17:(2):1994;80-85
194. Kask A., Rago L., Harro J. NPY Y1 receptors in the dorsal periaqueductal gray matter regulate anxiety in the social interaction test. Neuroreport. 9:(12):1998;2713-2716
195. Martins A.P., Marras R.A., Guimaraes F.S. Anxiogenic effect of corticotropin-releasing hormone in the dorsal periaqueductal grey. Neuroreport. 8:(16):1997;3601-3604
196. Sheriff S., Dautzenberg F.M., Mulchahey J.J., et al. Interaction of neuropeptide Y and corticotropin-releasing factor signaling pathways in AR-5 amygdalar cells. Peptides. 22:(12):2001;2083-2089
197. Heilig M., Soderpalm B., Engel J.A., Widerlov E. Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models. Psychopharmacologia. 98:(4):1989;524-529
198. Heilig M., McLeod S., Brot M., et al. Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects. Neuropsychopharmacology. 8:(4):1993;357-363
199. Broqua P., Wettstein J.G., Rocher M.N., Gauthier-Martin B., Junien J.L. Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures. Behav Pharmacol. 6:(3):1995;215-222
200. Heilig M., McLeod S., Koob G.K., Britton K.T. Anxiolytic-like effect of neuropeptide Y (NPY), but not other peptides in an operant conflict test. Regul Pept. 41:(1):1992;61-69
201. Zukowska-Grojec Z., Neuropeptide Y. A novel sympathetic stress hormone and more. Ann N Y Acad Sci. 771:1995;219-233
202. Yamada K., Shibasaki T., Tsumori C., et al. Neuropeptide Y reverses corticotropin-releasing hormone- and psychological stress-caused shortening of sodium pentobarbital-induced sleep in rats. Brain Res. 725:(2):1996;272-275
203. Heilig M., Widerlov E. Neurobiology and clinical aspects of neuropeptide Y. Crit Rev Neurobiol. 9:1995;115-136
204. Lundberg J.M., Martinsson A., Hemsen A., et al. Co-release of neuropeptide Y and catecholamines during physical exercise in man. Biochem Biophys Res Commun. 133:(1):1985;30-36
205. Kaijser L., Pernow J., Berglund B., Lundberg J.M. Neuropeptide Y is released together with noradrenaline from the human heart during exercise and hypoxia. Clin Physiol. 10:(2):1990;179-188
206. Morris M.J., Russell A.E., Kapoor V., et al. Increases in plasma neuropeptide Y concentrations during sympathetic activation in man. J Auton Nerv Syst. 17:(2):1986;143-149
207. Pernow J., Lundberg J.M., Kaijser L., et al. Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man. Clin Physiol. 6:(6):1986;561-578
208. Rasmusson A.M., Southwick A.M., Hauger S.M., Charney R.L., Dennis S. Plasma neuropeptide Y (NPY) increases in humans in response to the [alpha]2 antagonist yohimbine. Neuropsychopharmacology. 19:(1):1998;95-98
209. Morgan C.A. III, Wang S., Southwick S.M., et al. Plasma neuropeptide-Y concentrations in humans exposed to military survival training. Biol Psychiatry. 47:(10):2000;902-909
210. Morgan C.A. III, Wang S., Rasmusson A., Hazlett G., Anderson G., Charney D.S. Relationship among plasma cortisol, catecholamines, neuropeptide Y, and human performance during exposure to uncontrollable stress. Psychosom Med. 63:(3):2001;412-422
211. Morgan C.A. III, Rasmusson A.M., Wang S., Hoyt G., Hauger R.L., Hazlett G. Neuropeptide-Y, cortisol, and subjective distress in humans exposed to acute stress: replication and extension of previous report. Biol Psychiatry. 52:(2):2002;136-142
212. Rasmusson A.M., Hauger R.L., Morgan C.A. III, Bremner J.D., Charney D.S., Southwick S.M. Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD. Biol Psychiatry. 47:(6):2000;526-539
213. Husum H., Mathe A.A. Early life stress changes concentrations of neuropeptide Y and corticotropin-releasing hormone in adult rat brain. Lithium treatment modifies these changes. Neuropsychopharmacology. 27:(5):2002;756-764
214. Tsutsumi T., Akiyoshi J., Hikichi T., et al. Suppression of conditioned fear by administration of CCKB receptor antisense oligodeoxynucleotide into the lateral ventricle. Pharmacopsychiatry. 34:(6):2001;232-237
215. Shlik J., Zhou Y., Koszycki D., Vaccarino F.J., Bradwejn J. Effects of CCK-4 infusion on the acoustic eye-blink startle and psychophysiological measures in healthy volunteers. J Psychopharmacol. 13:(4):1999;385-390
216. Dauge V., Pophillat M., Crete D., Melik-Parsadaniantz S., Roques B.P. Involvement of brain endogenous cholecystokinin in stress-induced impairment of spatial recognition memory. Neuroscience. 118:(1):2003;19-23
217. Abelson J.L., Young E.A. Hypothalamic-pituitary adrenal response to cholecystokinin-B receptor agonism is resistant to cortisol feedback inhibition. Psychoneuroendocrinology. 28:(2):2003;169-180
218. Bhatnagar S., Viau V., Chu A., Soriano L., Meijer O.C., Dallman M.F. A cholecystokinin-mediated pathway to the paraventricular thalamus is recruited in chronically stressed rats and regulates hypothalamic-pituitary-adrenal function. J Neurosci. 20:(14):2000;5564-5573
219. Kim H., Whang W.W., Kim H.T., et al. Expression of neuropeptide Y and cholecystokinin in the rat brain by chronic mild stress. Brain Res. 983:2003;201-208
220. Kellner M., Wiedemann K., Yassouridis A., et al. Behavioral and endocrine response to cholecystokinin tetrapeptide in patients with posttraumatic stress disorder. Biol Psychiatry. 47:(2):2000;107-111
221. Adamec R.E., Shallow T., Budgell J. Blockade of CCK(B) but not CCK(A) receptors before and after the stress of predator exposure prevents lasting increases in anxiety-like behavior: implications for anxiety associated with posttraumatic stress disorder. Behav Neurosci. 111:(2):1997;435-449
222. Cohen H., Kaplan Z., Kotler M. CCK-antagonists in a rat exposed to acute stress: implication for anxiety associated with post-traumatic stress disorder. Depress Anxiety. 10:(1):1999;8-17
223. Tsutsumi T., Akiyoshi J., Isogawa K., Kohno Y., Hikichi T., Nagayama H. Suppression of conditioned fear by administration of CCKB receptor antagonist PD135158. Neuropeptides. 33:(6):1999;483-486
224. Pearlin L.I., Schooler C. The structure of coping. J Health Soc Behav. 19:(1):1978;2-21
225. Rose S, Bisson J, Wessely S. Psychological debriefing for preventing post-traumatic stress disorder (PTSD) (Cochrane review). In: The Cochrane library, Issue 1, 2003. Oxford: Update Software